表紙
市場調查報告書

歐洲的顯影劑及放射性醫藥品市場分析:2019年

Contrast Agents and Radiopharmaceuticals | Europe | 2019 | Market Analysis

出版商 Millennium Research Group - DRG 商品編碼 339435
出版日期 內容資訊 英文 108 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的顯影劑及放射性醫藥品市場分析:2019年 Contrast Agents and Radiopharmaceuticals | Europe | 2019 | Market Analysis
出版日期: 2018年07月23日內容資訊: 英文 108 Pages
簡介

償付法規嚴格以GBCA為中心對安全性相關討論持續之中,歐洲的顯影劑及放射性醫藥品市場,由於放射性醫藥品領域平均銷售價格上升,及人口的高齡化等要素,到2027年緩慢地成長。

本報告提供歐洲的顯影劑及放射性醫藥品市場現狀與今後10年的預測,以及各分類市場的競爭趨勢,市場佔有率等彙整資料。

第1章 顯影劑及放射性醫藥品市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 市場發展
  • 競爭因素與策略

第2章 放射性醫藥品市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
    • SPECT
    • PET
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

第3章 CT及X光掃描顯影劑市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
    • CT
    • 心血管用X光掃描
    • 一般的X光掃描
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

第4章 MRI顯影劑市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

第5章 超音波顯影劑市場

  • 市場亮點
  • 市場定義
  • 市場預測資料
  • 整體的市場趨勢
  • 競爭亮點
  • 市場佔有率
  • 競爭因素與策略

調查方法

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: M360RP0009

Despite stringent reimbursement regulations and the ongoing safety controversy surrounding GBCAs, the European contrast agent and radiopharmaceutical market will exhibit slight growth through 2027, propelled by ASP hikes in the radiopharmaceutical space and the increasing demand for diagnostic imaging procedures for Europe's aging population.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.

Recent studies have questioned the safety of GBCAs

  • How has the EMA responded to studies that call into question the safety of GBCAs?
  • To what extent will these studies impact the MRI contrast agent market through 2027?
  • How can competitors best respond to these safety concerns such that the impact on their products and revenues can be minimized?

Global fluctuations in the supply of Mo-99-the key isotope in the production of Tc for use in most SPECT procedures-will continue to negatively impact the market going forward

  • To what extent will supply limitations affect revenue growth in the European SPECT radiopharmaceutical market?

Less contrast material is being used per patient procedure in Europe

  • What are some of the key factors driving this trend?
  • What novel technology will contribute to this trend in the future?
  • Which markets will be the most impacted by this shift in usage?

The European market is more competitive compared to the US market

  • What are the key factors end users look for in a product?
  • How do local competitors fare compared to MNCs in the European contrast agent and radiopharmaceutical market?
  • How can smaller companies best position themselves to garner more market share going forward?

Table of Contents

Table of Contents

Tables and Figures

Executive Summary

Version History.

1 Contrast Agent and Radiopharmaceutical Market

  • 1.1 Market Highlights
  • 1.2 Market Definitions
  • 1.3 Market Forecast Data
  • 1.4 General Market Trends
  • 1.5 Competitive Highlights
  • 1.6 Market Shares
  • 1.7 Market Developments
  • 1.8 Competitive Factors and Strategies

2 Radiopharmaceutical Market

  • 2.1 Market Highlights
  • 2.2 Market Definitions
  • 2.3 Market Forecast Data
    • 2.3.1 SPECT Radiopharmaceuticals
    • 2.3.2 PET Radiopharmaceuticals
  • 2.4 General Market Trends
  • 2.5 Competitive Highlights
  • 2.6 Market Shares
  • 2.7 Competitive Factors and Strategies

3 CT and X-Ray Contrast Agent Market

  • 3.1 Market Highlights
  • 3.2 Market Definitions
  • 3.3 Market Forecast Data
    • 3.3.1 Computed Tomography
    • 3.3.2 Cardiovascular X-Ray
    • 3.3.3 Conventional X-Ray
  • 3.4 General Market Trends
  • 3.5 Competitive Highlights
  • 3.6 Market Shares
  • 3.7 Competitive Factors and Strategies

4 MRI Contrast Agent Market

  • 4.1 Market Highlights
  • 4.2 Market Definitions
  • 4.3 Market Forecast Data
  • 4.4 General Market Trends
  • 4.5 Competitive Highlights
  • 4.6 Market Shares
  • 4.7 Competitive Factors and Strategies

5 Ultrasound Contrast Agent Market

  • 5.1 Market Highlights
  • 5.2 Market Definitions
  • 5.3 Market Forecast Data
  • 5.4 General Market Trends
  • 5.5 Competitive Highlights
  • 5.6 Market Share Rankings
  • 5.7 Competitive Factors and Strategies

Methodology

  • Core Country Coverage Methodology
  • Supplemental Country Coverage Methodology

Appendix: Acronyms and Initialisms

Appendix: Bibliography

Tables and Figures

  • Table 1: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Figure 1: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027
  • Table 2: Contrast Agent and Radiopharmaceutical Market Landscape, Europe (USD), 2018 and 2027
  • Table 3: Competitive Factors and Strategies, by Product Type, Europe
  • Table 4: Contrast Agent and Radiopharmaceutical Procedure Market Share Rankings, by Product Type, Europe, 2018
  • Table 5: Companies Mentioned
  • Table 6: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Table 7: Geographies Covered, Europe
  • Table 8: Average Currency Exchange Rates
  • Table 9: Contrast Agents and Radiopharmaceutical Procedures and Products Covered, Europe
  • Table 10: Version History
  • Table 11: Factors Impacting the Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe
  • Figure 2: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027
  • Figure 3: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 12: Contrast Agent and Radiopharmaceutical Procedures, by Product Type, Europe, 2017-2027
  • Table 13: Contrast Agent and Radiopharmaceutical Procedures, by Country, Europe, 2017-2027
  • Table 14: Contrast Agent and Radiopharmaceutical Market, by Product Type, Europe (USD and EUR), 2017-2027
  • Table 15: Contrast Agent and Radiopharmaceutical Market, by Country, Europe (USD, EUR, and GBP), 2017-2027
  • Figure 4: Contrast Agent and Radiopharmaceutical Procedure Market Shares, Europe, 2018
  • Table 16: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2018
  • Table 17: Contrast Agent and Radiopharmaceutical Procedure Market Shares, by Product Type, Europe, 2018
  • Table 18: Recent Events in the Contrast Agent and Radiopharmaceutical Market, Europe
  • Table 19: Competitive Factors and Strategies, by Product Type, Europe
  • Figure 5: Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027
  • Figure 6: Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 20: Radiopharmaceutical Market, by Product Type, Europe (USD), 2017-2027.
  • Table 21: Radiopharmaceutical Market, by Product Type, Europe (EUR), 2017-2027
  • Table 22: Radiopharmaceutical Market Growth, by Product Type, Europe, 2018-2027
  • Table 23: Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 24: Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 25: Radiopharmaceutical Market Growth, by Country, Europe, 2018-2027
  • Table 26: Nuclear Medicine System Installed Base, by Product Type, Europe, 2017-2027
  • Table 27: Nuclear Medicine System Ins talled Base, by Country, Europe, 2017-2027
  • Table 28: SPECT Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 29: SPECT Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 30: SPECT Radiopharmaceutical Market Growth, by Country, Europe, 2018-2027
  • Table 31: SPECT Radiopharmaceutical Installed Base, by Country, Europe, 2017-2027
  • Table 32: PET Radiopharmaceutical Market, by Country, Europe (USD), 2017-2027
  • Table 33: PET Radiopharmaceutical Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 34: PET Radiopharmaceutical Market Growth, by Country, Europe, 2018-2027
  • Table 35: PET Radiopharmaceutical Installed Base, by Country, Europe, 2017-2027
  • Figure 7: SPECT Radiopharmaceutical Procedure Market Shares, Europe, 2018
  • Table 36: SPECT Radiopharmaceutical Procedure Market Shares, by Country, Europe, 2018
  • Table 37: Competitive Factors and Strategies, Europe
  • Figure 8: CT and X-Ray Contrast Agent Market, by Product Type, Europe (USD), 2017-2027
  • Figure 9: CT and X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 38: CT and X-Ray Contrast Agent Market, by Product Type, Europe (USD), 2017-2027
  • Table 39: CT and X-Ray Contrast Agent Market, by Product Type, Europe (EUR), 2017-2027
  • Table 40: CT and X-Ray Contrast Agent Market Growth, by Product Type, Europe, 2018-2027
  • Table 41: CT and X-Ray System Installed Base, by Country, Europe, 2017-2027.
  • Table 42: CT and X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 43: CT and X-Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 44: CT and X-Ray Contrast Agent Market Growth, by Country, Europe, 2018- 2027
  • Table 45: CT System Ins talled Base, by Country, Europe, 2017-2027
  • Table 46: X-Ray System Installed Base, by Country, Europe, 2017-2027
  • Table 47: CT Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 48: CT Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 49: CT Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 50: Cardiovascular X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 51: Cardiovascular X-Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 52: Cardiovascular X-Ray Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 53: Conventional X-Ray Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 54: Conventional X-Ray Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 55: Conventional X-Ray Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Figure 10: CT and X-Ray Contrast Agent Procedure Market Shares, Europe, 2018
  • Table 56: CT and X-Ray Contrast Agent Procedure Market Shares, by Country, Europe, 2018
  • Table 57: Competitive Factors and Strategies, Europe
  • Figure 11: MRI Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 58: MRI Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 59: MRI Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 60: MRI Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 61: MRI System Installed Base, by Country, Europe, 2017-2027.
  • Figure 12: MRI Contrast Agent Procedure Market Shares, Europe, 2018
  • Table 62: MRI Contrast Agent Procedure Market Shares, by Country, Europe, 2018
  • Table 63: Competitive Factors and Strategies, Europe
  • Figure 13: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 64: Ultrasound Contrast Agent Market, by Country, Europe (USD), 2017-2027
  • Table 65: Ultrasound Contrast Agent Market, by Country, Europe (EUR and GBP), 2017-2027
  • Table 66: Ultrasound Contrast Agent Market Growth, by Country, Europe, 2018-2027
  • Table 67: Ultrasound Contrast Agent Revenue Market Share Rankings, Europe, 2018
  • Table 68: Competitive Factors and Strategies, Europe.
  • Table 69: Acronyms and Initialisms
Back to Top